Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma
Yewlin E. Chee
Raghu Mudumbai
Steven S. Saraf
Thellea Leveque
Verena S. Grieco
Monique A. Mogensen
Rebecca A. Yoda
Luis F. Gonzalez-Cuyar
Andrew W. Stacey
Andrew Stacey
Stacey Andrew
/ Andrew W Stacey
ORCID: 0000-0002-4441-6302
The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey
10.3390/cancers13194773
Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy
10.1136/bjophthalmol-2020-316862
The addition of topotecan to melphalan in the treatment of retinoblastoma with intra-arterial chemotherapy
10.1016/j.oret.2020.11.007
Incidence of retinoblastoma has increased: results from 40 European countries
10.1016/j.ophtha.2021.01.024
Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries
10.3390/cancers13081956
Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma
10.1016/j.ajoc.2021.101173
Luis Gonzalez-Cuyar
Gonzalez-Cuyar Luis
ORCID: 0000-0002-8424-8331
Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression
10.1038/s41598-018-19308-y
Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
10.1158/2159-8290.CD-17-1368
From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response
10.1101/650150
Cellular respiration and tumor suppressor genes
10.1007/978-1-59745-435-3_10
Gadolinium tissue deposition in brain and bone
10.1016/j.mri.2016.08.025
Redox active iron accumulation in aceruloplasminemia
10.1111/j.1440-1789.2008.00901.x
Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: Preliminary results from 9 patients with normal renal function
10.1097/RLI.0000000000000252
Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment
10.1007/s11910-011-0212-0
Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant
10.1016/j.nmd.2018.04.010
Monomorphic post-transplant lymphoproliferative disorder of the tongue: Case report and review of literature
10.1186/1746-1596-2-49
Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case
10.1016/j.wneu.2018.06.227
Salivary tau species are potential biomarkers of alzheimer's disease
10.3233/JAD-2011-110731
Multiplex immunoassays of peptide hormones extracted from formalin-fixed, paraffin-embedded tissue accurately subclassify pituitary adenomas
10.1373/clinchem.2011.170613
Primary Gliosarcoma of the Optic Nerve: A Unique Adult Optic Pathway Glioma
10.1097/IOP.0000000000000798
Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control
10.1016/j.neurobiolaging.2013.08.008
Cerebrotendinous xanthomatosis: Case report with evidence of oxidative stress
10.1179/135100007X200173
Somatic PDGFRB Activating Variants in Fusiform Cerebral Aneurysms
10.1016/j.ajhg.2019.03.014
Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults
10.1111/j.1750-3639.2011.00542.x
Cerebrotendinous xanthomatosis: A critical update
10.2217/14796708.3.4.491
Fatal parvoviral myocarditis: A case report and review of literature
10.1186/1746-1596-3-21
Clival paragangliomas: a report of two cases involving the midline skull base and review of the literature
10.1007/s11060-017-2396-x
Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: Evidence for multicentric T-cell lymphoproliferative process
10.1186/1746-1596-3-22
Alternative splicing in a presenilin 2 variant associated with Alzheimer disease
10.1002/acn3.755
Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection
10.1016/S1473-3099(08)70067-7
Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice
10.1111/his.13345
Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region
10.1227/NEU.0000000000000877
Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients
10.1172/JCI76739
Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival
10.1200/CCI.17.00080
Cerebral cortical Aβ 42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE
10.1097/NEN.0000000000000153
Comparative Proteomic Profiling Using Two-Dimensional Gel Electrophoresis and Identification via LC-MS/MS Reveals Novel Protein Biomarkers to Identify Aggressive Subtypes of WHO Grade i Meningioma
10.1055/s-0037-1601889
Sodium polystyrene sulfonate (Kayexalate) aspiration
10.1186/1746-1596-3-27
In the Eye of the Beholder: A Conjunctival Lesion in a Woman with Acute Myelogenous Leukemia
10.1093/cid/ciy394
Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes
10.1186/s13059-014-0530-z
Extra-oral plasmablastic lymphoma: report of a case and review of literature
10.1016/j.humpath.2006.04.009
Quantitative neuropathology associated with chronic manganese exposure in South African mine workers
10.1016/j.neuro.2013.12.008
Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son
10.3233/JHD-170261
Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma
10.1080/2162402X.2018.1507668
Ex vivo magnetic resonance imaging in South African manganese mine workers
10.1016/j.neuro.2015.04.002
Bilateral internal carotid absence: a case report of a rare congenital anomaly
10.1016/j.carpath.2007.04.009
Endothelial activation and blood–brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells
10.1158/2159-8290.CD-17-0698
Sudden unexpected death in lymphocytic hypophysitis
10.1097/PAF.0b013e3181873851
Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker.
10.1158/1078-0432.ccr-18-0641
ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach.
10.1097/coc.0000000000000564
From Herniation to Rehabilitation: A Young Woman With Rapidly Progressive Neurological Deficits.
10.1177/1941874419832437
Hyperphosphorylated Tau, Increased Adenylate Cyclase 5 (ADCY5) Immunoreactivity, but No Neuronal Loss in ADCY5‐Dyskinesia
10.1002/mdc3.12873
Intraoperative assessment of skull base tumors using stimulated Raman scattering microscopy
10.1038/s41598-019-56932-8
From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response
10.1371/journal.pcbi.1007672
Effect of formalin fixation on measured concentrations of deposited gadolinium in human tissue: an autopsy study
10.1177/0284185121994047
Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate
10.1148/radiol.2021204320
Operational Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic and Early Recovery Trends: University of Washington Anatomic Pathology Experience
10.5858/arpa.2020-0639-sa
Rapid Validation of Telepathology by an Academic Neuropathology Practice During the COVID-19 Pandemic
10.5858/arpa.2020-0372-sa
Variability in hair gadolinium concentrations among decedents who received gadolinium-based contrast agents
10.1007/s00216-020-03116-3
Human Hair as a Possible Surrogate Marker of Retained Tissue Gadolinium
10.1097/rli.0000000000000681
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients
10.1186/s12885-020-06816-2
Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma
10.1016/j.ajoc.2021.101173
